RO4929097 - γ-Secretase Inhibitor. CAS#847925-91-1 326 Modulation of histone acetylation by

Modulation of histone acetylation by [4-(acetylamino)-N-(2-amino-phenyl) benzamide] in HCT-8 colon carcinoma

inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy

HLY78 as a specific Wnt synergistic activator presents another opportunity for potential clinical applications relevant to the Wnt pathway

1801747-11-4

RO4929097 - γ-Secretase Inhibitor. CAS#847925-91-1 326 Modulation of histone acetylation byRO4929097, CAS No. 847925 91 1, is a highly potent and selective secretase inhibitor with an IC50 ~4 nM. It can cause a dramatic reduction of the intracellular Notch level and lead to significantly decreased expression of the Notch transcriptional target genes, such as Hes1. It exhibits potent inhibitory activity of Notch signaling in tumor cells. Currently RO4929097 is in multiple phase I II clinical trials to treat cancer. Product information CAS